Clinical Infectious Diseases: Open Access

ISSN: 2684-4559

Open Access

Current Issue

Volume 4, Issue 2 (2020)

    Editor Note Pages: 1 - 1

    Editorial Note for Clinical Infectious Diseases: Open Access.

    Serkan Atici

    DOI: jid.2020.4

    Clinical Infectious Diseases: Open Access (ISSN: 2684-4559) is
    growing continuously. It is our pleasure to announce that during year
    2019, all issues of volume 3 were published online on time and the
    print issues were also brought out and dispatched within 30 days of
    publishing the issue online.
    All published articles of this journal are included in the indexing
    and abstracting coverage of CAS Source Index (CASSI), Index
    Copernicus, Google Scholar, Sherpa Romeo, RefSeek, EBSCO A-Z,
    OCLC- WorldCat, SWB online catalog, Publons, etc.
    During the calendar year 2019, JID received a total of 7 papers,
    out of which 1 article were rejected in the preliminary screening due
    to plagiarism or being out of the format and peer review process.
    During 2019 around 5 articles were subjected for publication after
    they are accepted in the peer review process. In the 3 issues of
    Volume 3 published during the year 2019, a total of 5 articles were
    published (at an average of 2 articles per issue) of which, articles
    were published from authors all around the world. Average
    publication lag time of an article was further reduced to 2-3 weeks.
    Clinical Infectious Diseases: Open Access its new association with
    Hilaris Publishing group for Archiving, Journal maintenance,
    financial purpose and support. Journal will be running its website
    parallel for Editorial and review work process so as to maintain its
    highest standard of scientific work.
    Association with Hilaris Publishing Group has increased
    Readership Metrics (By Google Analytics) of Clinical Infectious
    Diseases: Open Access at the same.
    Clin Infect Dis, an open accessjournal
    I take this opportunity to acknowledge the contribution by Editors:
    Dr. Pere Domingo, Associate Editors: Omer Faruk Ozkan and also
    during the final editing of articles published and the support rendered
    by the editorial assistants bringing out issues of JID in time. I would
    also like to express my gratitude to all the Editors, authors, reviewers,
    the publisher, the advisory, and the editorial board of JID, the office
    bearers for their support in bringing out yet another volume of JID and
    look forward to their unrelenting support to bring out the Volume 4
    and upcoming Volume 5 of JID in scheduled time.

    Short Communication Pages: 1 - -2

    Lacticodeshydrogénase (LDH) and Ferrétinémia, Biomarkers of Coronavirus Disease (COVID-19).

    Nawal Brikci Nigassa and Mustapha Haddouche*

    DOI: 10.37421/jid.2020.4.118/

    Coronavirus disease (COVID-19) is caused by SARS-COV2 and represents the causative agent of a potentially fatal disease that is of great global public health concern.
    Its involves humans as well as animals and may cause serious damage to the respiratory tract, including the lung: coronavirus disease (COVID-19). This pathogenic virus
    has been identified in swabs performed on the throat and nose of patients who suffer from or are suspected of the disease. Based on the large number of infected people
    that were exposed to the wet animal market in Wuhan City, China, it is suggested that this is likely the zoonotic origin of COVID-19.

Relevant Topics

Recommended Conferences

Antibiotics: Discovery & Development

New York, USA

Infectious Diseases and Control

New York, USA

World Pathology Congress 2020

New York, USA
arrow_upward arrow_upward